Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Path to Surfaxin approval looks less costly for Discovery Labs after FDA guidance
Path to Surfaxin approval looks less costly for Discovery Labs after FDA guidance
Path to Surfaxin approval looks less costly for Discovery Labs after FDA guidance
Submitted by
admin
on February 16, 2010 - 10:46am
Source:
Bizjournals.com
News Tags:
Surfaxin
FDA
Discovery Labs
Headline:
Path to Surfaxin approval looks less costly for Discovery Labs after FDA guidance
Do Not Allow Advertisers to Use My Personal information
